Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
ACTIVE_NOT_RECRUITING
Status
Conditions
- Stage I Chronic Lymphocytic Leukemia
- Stage II Chronic Lymphocytic Leukemia
- Stage III Chronic Lymphocytic Leukemia
- Stage IV Chronic Lymphocytic Leukemia
Interventions
- DRUG: Bendamustine Hydrochloride
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: Computed Tomography
- DRUG: Ibrutinib
- OTHER: Laboratory Biomarker Analysis
- OTHER: Quality-of-Life Assessment
- BIOLOGICAL: Rituximab
Sponsor
National Cancer Institute (NCI)